What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

A common clinical question for medical oncologists treating metastatic castration-resistant prostate cancer is, should patients who previously received docetaxel and progress on it, reuse docetaxel or ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

Israel releases Benjamin Netanyahu’s medical report confirming no prostate cancer, stable heart condition, and treatment for ...

A new study in Austria has shown that a special ultrasound treatment can effectively control early prostate cancer while helping men keep their quality of life. This method targets only the part of ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...

On this Valentine's Day, a couple recalls everything they had to overcome from long distance to three cancer diagnoses over ...

An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to neurodegenerative disease.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

Black men have one of the highest rates of prostate cancer. In fact, 1 in 6 will develop the disease in their lifetimes. And we also have twice the risk of dying from prostate cancer compared to White ...